Almirall, S.A. (OTCMKTS:LBTSF) Sees Large Decline in Short Interest

Almirall, S.A. (OTCMKTS:LBTSF) was the target of a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 85,600 shares, a drop of 12.5% from the December 31st total of 97,800 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Almirall Price Performance

LBTSF remained flat at $9.17 during trading on Monday. The firm’s fifty day simple moving average is $9.17 and its 200-day simple moving average is $9.39. Almirall has a 52 week low of $9.17 and a 52 week high of $9.17.

Almirall Company Profile

Almirall, SA, a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations.